Forecasting therapeutic responses by albuminuria and eGFR slope during the DAPA-CKD trial

达帕格列嗪 医学 危险系数 糖尿病 安慰剂 内科学 2型糖尿病 糖尿病肾病 蛋白尿 肾功能 疾病 肾脏疾病 重症监护医学 内分泌学 置信区间 病理 替代医学
作者
Katherine R. Tuttle
出处
期刊:The Lancet Diabetes & Endocrinology [Elsevier BV]
卷期号:9 (11): 727-728 被引量:2
标识
DOI:10.1016/s2213-8587(21)00265-5
摘要

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial is a landmark study that, along with a rapidly growing body of evidence, has firmly established SGLT2 inhibition as new standard of care for people with type 2 diabetes and chronic kidney disease. 1 Heerspink HJL Stefánsson BV Correa-Rotter R et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020; 383: 1436-1446 Crossref PubMed Scopus (969) Google Scholar , 2 de Boer IH Caramori ML Chan JCN et al. Kidney Disease: Improving Global Outcomes (KDIGO) diabetes work group. KDIGO 2020 Clinical Practice Guideline for diabetes management in chronic kidney disease. Kidney Int. 2020; 98: S1-115 Summary Full Text Full Text PDF PubMed Scopus (280) Google Scholar DAPA-CKD investigated dapagliflozin versus placebo in participants who had chronic kidney disease with or without type 2 diabetes. The primary outcome (50% decline in estimated glomerular filtration rate [eGFR], kidney failure, or death due to kidney disease or cardiovascular disease) was positive for dapagliflozin (hazard ratio 0·69, 95% CI 0·51–0·72). DAPA-CKD was stopped early because of overwhelming efficacy and, notably, was the first dedicated kidney disease outcomes trial to report similar benefits in diabetic and non-diabetic chronic kidney disease. Since the initial publication of DAPA-CKD, 1 Heerspink HJL Stefánsson BV Correa-Rotter R et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020; 383: 1436-1446 Crossref PubMed Scopus (969) Google Scholar additional analyses continue to provide more knowledge by detailed descriptions and evaluation of various subgroups or outcomes. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trialDapagliflozin significantly slowed long-term eGFR decline in patients with chronic kidney disease compared with placebo. The mean difference in eGFR slope between patients treated with dapagliflozin versus placebo was greater in patients with type 2 diabetes, higher HbA1c, and higher UACR. Full-Text PDF Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trialIn patients with chronic kidney disease with and without type 2 diabetes, dapagliflozin significantly reduced albuminuria, with a larger relative reduction in patients with type 2 diabetes. The similar effects of dapagliflozin on clinical outcomes in patients with or without type 2 diabetes, but different effects on UACR, suggest that part of the protective effect of dapagliflozin in patients with chronic kidney disease might be mediated through pathways unrelated to reduction in albuminuria. Full-Text PDF
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
丘比特的应助被yzm采纳,获得10
1秒前
1秒前
赘婿的应助被yugui采纳,获得10
2秒前
宿江完成签到,获得积分10
2秒前
思源的应助被Xenia采纳,获得10
2秒前
瑾风阳完成签到,获得积分10
2秒前
saturn发布了新的文献求助10
3秒前
qiuyu发布了新的文献求助10
3秒前
3秒前
4秒前
molihuakai的应助被lyy采纳,获得10
5秒前
涵汉堡包完成签到,获得积分10
5秒前
天天向上的应助被知许采纳,获得10
5秒前
可爱玫瑰完成签到,获得积分10
5秒前
6秒前
Lich完成签到,获得积分10
6秒前
Harvest发布了新的文献求助20
7秒前
llllllllxxy完成签到,获得积分10
7秒前
西瓜皮发布了新的文献求助10
7秒前
少帅的科研路完成签到,获得积分20
8秒前
kkkk关注了科研通微信公众号
8秒前
zbn发布了新的文献求助30
8秒前
9秒前
学止境关注了科研通微信公众号
9秒前
9秒前
00完成签到 ,获得积分10
10秒前
Lich发布了新的文献求助10
10秒前
HHW发布了新的文献求助10
10秒前
cx完成签到,获得积分10
10秒前
shidewu发布了新的文献求助20
10秒前
开朗发卡完成签到,获得积分10
10秒前
嘟嘟嘟嘟完成签到,获得积分10
10秒前
10秒前
daomaihu发布了新的文献求助100
10秒前
molihuakai的应助被李飘飘采纳,获得10
11秒前
汉堡包的应助被阿九采纳,获得10
12秒前
12秒前
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178375
求助须知:如何正确求助?哪些是违规求助? 9569182
关于积分的说明 21802781
捐赠科研通 7773247
什么是DOI,文献DOI怎么找? 3432799
关于科研通互助平台的介绍 2556793
邀请新用户注册赠送积分活动 2478346